239 related articles for article (PubMed ID: 17097359)
1. Biomarker discovery from body fluids using mass spectrometry.
Villar-Garea A; Griese M; Imhof A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
[TBL] [Abstract][Full Text] [Related]
2. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids.
Gagnon A; Shi Q; Ye B
Methods Mol Biol; 2008; 441():41-56. PubMed ID: 18370310
[TBL] [Abstract][Full Text] [Related]
5. FTMS and TOF/TOF mass spectrometry in concert: identifying peptides with high reliability using matrix prespotted MALDI target plates.
Dekker LJ; Burgers PC; Guzel C; Luider TM
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):62-4. PubMed ID: 16963321
[TBL] [Abstract][Full Text] [Related]
6. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
Ndao M
Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
10. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry.
Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ
Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144
[TBL] [Abstract][Full Text] [Related]
11. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
[TBL] [Abstract][Full Text] [Related]
12. Modified silver nanoparticle as a hydrophobic affinity probe for analysis of peptides and proteins in biological samples by using liquid-liquid microextraction coupled to AP-MALDI-ion trap and MALDI-TOF mass spectrometry.
Shrivas K; Wu HF
Anal Chem; 2008 Apr; 80(7):2583-9. PubMed ID: 18324794
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices.
Poon TC
Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515
[TBL] [Abstract][Full Text] [Related]
14. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
[TBL] [Abstract][Full Text] [Related]
15. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
16. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
17. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates.
Rainer M; Muhammad NU; Huck CW; Feuerstein I; Bakry R; Huber LA; Gjerde DT; Zou X; Qian H; Du X; Wei-Gang F; Ke Y; Bonn GK
Rapid Commun Mass Spectrom; 2006; 20(19):2954-60. PubMed ID: 16953521
[TBL] [Abstract][Full Text] [Related]
18. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
19. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
20. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
Harezlak J; Wang M; Christiani D; Lin X
Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]